0 (0%) | 09-27 11:11 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 44.58 ![]() |
1-year : | 52.07 ![]() |
Resists | First : | 38.16 ![]() |
Second : | 44.58 ![]() |
Pivot price | 36.68 ![]() |
|||
Supports | First : | 35.8 ![]() |
Second : | 34.34 ![]() |
MAs | MA(5) : | 37.43 ![]() |
MA(20) : | 36.51 ![]() |
MA(100) : | 32.45 ![]() |
MA(250) : | 33.12 ![]() |
|
MACD | MACD : | 0.7 ![]() |
Signal : | 0.7 ![]() |
%K %D | K(14,3) : | 82.3 ![]() |
D(3) : | 81.9 ![]() |
RSI | RSI(14): 64.8 ![]() |
|||
52-week | High : | 42.72 | Low : | 22.32 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ SBIO ] has closed Bollinger Bands are 8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 38.21 - 38.39 | 38.39 - 38.55 |
Low: | 36.6 - 36.81 | 36.81 - 37 |
Close: | 37.85 - 38.18 | 38.18 - 38.47 |
Thu, 11 Sep 2025
3 Stocks Driving Biotech ETF SBIO’s Appeal - ETF Database
Fri, 29 Aug 2025
This Underrated Tech ETF Is Spiking Amid Rate Cut Hype - ETF Trends
Tue, 26 Aug 2025
Earnings Flash (SBIO.V) Sabio Holdings Reported Overnight Q2 Revenue US$11.2M, vs. FactSet Est of $10.4M - MarketScreener
Fri, 15 Aug 2025
Is Biotech the Right Tech ETF Move Right Now? SBIO Argues Yes - ETF Trends
Thu, 10 Jul 2025
Small-Cap Biotech Stocks Ready to Shine - ETF Trends
Thu, 08 May 2025
UNAIR Professor advances innovation in tissue engineering and artificial organs - unair.ac.id
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |